@pooja_varman presents Second Opinions, Same Standards. Some delays occur, but patients should be encouraged to seek second opinion as no significant delays in therapy exist. #ASBrS2025@ASBrS
👏👏Excellent overview by @chibaAkiko on how social media may impact health outcomes!!🧐🧐 Physician education, patient education, public health notifications, counter misinformation, and more!! 🙌🙌 #ASBRS24
Very interesting study by @AnnaWeissMD regarding genetic testing for surgical decision making. We need to change the way we test as we increase the number of patients tested and assure our patients really understand their future risks of contralateral cancer. #asbrs24@ASBrS
So proud of Alex Moore highlighting the clinical implications of cALND in pts with +TAD. 45% had ⬆️RCB from additional disease on cALND. No data yet to support oncologic safety of omitting cALND for +TAD. @MDAndersonNews @drmediget @ASBrS#ASBrS24#precisionmatters
Interesting presentation by @katfleshner on diagnostic delays in young pts - primarily patient delays vs system delays highlighting the need for provider & pt education on recognizing signs and symptoms which may be different in this population #ASBrS24@ASBrS
Excellent Canadian 🇨🇦 study on young women w/#BreastCancer by @katfleshner 👏. Healthcare system working well and opportunities to educate young women re: signs/symptoms of breast cancer. @ASBrS#ASBrS24
Important presentation by @AlexaGlencer highlighting NON-guideline concordant care of IBC. In the era of de-escalation, education is needed to avoid non-data backed care. All IBC pts need trimodal therapy with modified radical mastectomy! @ASBrS@MDAndersonNews#ASBrS24
Should we exclude anyone from cancer genetic testing?
Dr. Euhus says “No”
We should be thoughtful about how we use genetic mutation information combined with other risk factors for breast cancer screening and risk reduction.
#ASBrS24
Dr. Julia White presents on radiation genomics including ongoing clinical trials using commercially available genomic assays to select low risk breast cancers for omission of RT #ASBrS24@ASBrS
Great talk on the use of MRI in beast cancer. There are some appropriate uses but it should not be used routinely in the preoperative work up of breast cancer. @ASBrS#ASBRS24